Physician profile
Danielle Lee
NPI 1679114532
$488.96
in general payments reported to CMS, 2019-2025
10 companies · $72.06 in 2025
The $72.06 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $397 · 2023: $19.53 · 2025: $72.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $112.89 | 2021-2025 | Invega Trinza, Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $98.95 | 2021 | |
| Abbvie INC. | $63.39 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $57.92 | 2021 | |
| Alkermes, INC. | $39.47 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $36.60 | 2021-2023 | Tecnis Iol |
| Indivior INC. | $30.16 | 2021 | |
| Lilly USA, LLC | $17.02 | 2025 | Emgality |
| Teva Pharmaceuticals USA, INC. | $16.56 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.00 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.